Diagnosis of massive PE.
EUSEM Academy. Horner D. 09/09/18; 227611; 38201 Disclosure(s)(s): I am a current guideline group member working with the National Institute of Health and Care Excellence, UK. I am affiliated to the Royal College of Emergency Medicine, UK. I am an independent adjudicator for a commercial study into magnetocardiotocograph technology funded and sponsored by CREAVO industries.
Dr. Daniel Horner
Dr. Daniel Horner
Only EUSEM-Members and Congress 2018 participants have access to the Congress 2018 content. To become a member click here
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
Understand how to evaluate cardiovascular stability in acute PE and the influence on outcome.
Understand the role of hypoxia evaluation in large PE
Understand the evidence regarding thrombus burden and prediction of adverse outcome in PE
Understand the role of continuing clinical evaluation in management of PE.
What does the term 'massive' mean when classifying pulmonary embolism, and why do we classify complex disease states? This talk discusses the most pertinent clinical features in classification of disease severity and highlights presenting features that may make us wish to do more than just anticoagulate.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies